Figure 3
From: A novel prognostic signature for hepatocellular carcinoma based on SUMOylation-related genes
Development of a novel prognostic signature. (a) Partial likelihood deviance versus log (lambda) drawn. (b) Expression levels of two genes in HCC and normal samples; (c) The K–M curve of model genes; (d) Immunohistochemical staining protein level from the HPA database; (e) The patients in the low-risk groups have significantly longer OS outcomes than those in the high-risk groups; (f) Risk score distribution in HCC patients, overall survival and survival status of HCC patients in the TCGA database.
